However, 68.4% of PTC-BRAFwt also showed a high score of NOX4 protein (Figure 2c), emphasizing that NOX4 expression could be upregulated in thyroid cancer independently of BRAF mutational status. This evidence concerns the gene BRAF and thyroid gland carcinoma.